Asmanex
Asmanex (mometasone furoate) is an inhaled corticosteroid (ICS) designed for the daily prevention and control of asthma symptoms. It works by reducing swelling and inflammation in the airways, making breathing easier over time. It is a controller medication and is not intended to treat sudden, acute asthma attacks (bronchospasm).
Dosage by Body Weight
Administered via oral inhalation. Dosing is determined by age, asthma severity, and previous asthma therapy, rather than body weight. To prevent oral thrush (candidiasis), patients must rinse their mouth thoroughly with water and spit it out after each inhalation. Typical pediatric dose (ages 4-11) is 110 mcg once daily. Typical adolescent/adult dose (ages 12+) is 220 mcg to 440 mcg daily.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Asmanex is not approved for use in infants. Safety and efficacy have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in this weight range; not approved for children under 4 years of age.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in this weight range; not approved for children under 4 years of age.
- Body Weight
- 11-15 kg
- Dose
- Not routine / Age-dependent
- Frequency
- Once daily (if 4 years or older)
- Tracking Notes
- Dosing is based on age and clinical response, not weight. If the child is 4 years of age or older, the standard dose is 110 mcg once daily in the evening.
- Body Weight
- 16-20 kg
- Dose
- Not routine / Age-dependent
- Frequency
- Once daily (if 4 years or older)
- Tracking Notes
- Dosing is based on age and clinical response, not weight. If the child is 4 years of age or older, the standard dose is 110 mcg once daily in the evening.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Asmanex is not approved for use in infants. Safety and efficacy have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in this weight range; not approved for children under 4 years of age. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in this weight range; not approved for children under 4 years of age. |
| 11-15 kg | Not routine / Age-dependent | Once daily (if 4 years or older) | Dosing is based on age and clinical response, not weight. If the child is 4 years of age or older, the standard dose is 110 mcg once daily in the evening. |
| 16-20 kg | Not routine / Age-dependent | Once daily (if 4 years or older) | Dosing is based on age and clinical response, not weight. If the child is 4 years of age or older, the standard dose is 110 mcg once daily in the evening. |
Formulation
Purpose
Long-term maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older.
Generic Name
Mometasone furoateScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.